title: [Venlafaxine titration dosage in depressive in-patients. A series of cases].
abstract: This series of patients was gathered to assess the use of last and slow titration dosage of venlafaxine in in-patients with major depression and to evaluate the action onset. An observational open study was performed in 3 centers in 18 in-patients. Nine patients were included in fast titration dosage group (FT) and 9 in slow titration dosage group (ST). As results, it was found that the FT group showed faster improvement than the ST group in HAM-D score. This improvement was sustained to the final visit, with a lower score in the FT group (6.75) than the ST group (10.67). MADRS scores up to the 15th visit were similar; however, the score was lower in the ST group on the 20th visit. Improvement was sustained to the final visit, the FT group score being lower (6.50) than the ST group score (14). CGI - i mprovement and CGI-seve rity scores we re similar to the above mentioned results. The most common events in both groups were considered mild. The data of these patients show faster response to antidepressant therapy with faster titration dosage, with maintenance of the molecule's tolerability profile.
authors.affiliation: Hospital Clínico, Barcelona, España. bernardo@medicina.ub.es
authors.forename: M
authors.initials: M
authors.lastname: Bernardo
authors.forename: E
authors.initials: E
authors.lastname: Buisán
authors.forename: A
authors.initials: A
authors.lastname: Durán
authors.forename: P A
authors.initials: PA
authors.lastname: Soler-Insa
authors.forename: J
authors.initials: J
authors.lastname: Gascón
authors.forename: J
authors.initials: J
authors.lastname: Alberni
authors.forename: R
authors.initials: R
authors.lastname: Prieto
mesh_terms: D000293:Adolescent; D000328:Adult; D003511:Cyclohexanols / Q000008:administration & dosage / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000534:rehabilitation*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000069470:Venlafaxine Hydrochloride
chemical_list: D003511:Cyclohexanols; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride